about
cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 casesMicrovessels Density in Uterine LeiomyosarcomaPersistent Morbillivirus Infection Leads to Altered Cortactin Distribution in Histiocytic Sarcoma Cells with Decreased Cellular Migration CapacityMitochondrial DNA plasticity is an essential inducer of tumorigenesis.YB-1 regulates tiRNA-induced Stress Granule formation but not translational repressionTransforming growth factor-β1 signaling promotes epithelial-mesenchymal transition-like phenomena, cell motility, and cell invasion in synovial sarcoma cells.Eribulin in advanced liposarcoma and leiomyosarcoma.Micro-Environmental Stress Induces Src-Dependent Activation of Invadopodia and Cell Migration in Ewing Sarcoma.Targeting group I p21-activated kinases to control malignant peripheral nerve sheath tumor growth and metastasis.Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma.Distinct subcellular localization of E-cadherin between epithelioid angiomyolipoma and triphasic angiomyolipoma: A preliminary case-control study.BMPR2 promotes invasion and metastasis via the RhoA-ROCK-LIMK2 pathway in human osteosarcoma cells.Restoration of desmosomal junction protein expression and inhibition of H3K9-specific histone demethylase activity by cytostatic proline-rich polypeptide-1 leads to suppression of tumorigenic potential in human chondrosarcoma cells.SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters.Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies.
P2860
Q33815876-301A7474-ACF4-4753-9275-A95C5FC99954Q34513965-EB919B30-4037-4302-9A9C-36C65959AED3Q35802466-54FE00D9-E4D5-4F16-9D50-208FD8B6AFCBQ36212006-4C4513B2-88F1-499E-B38D-173550E5A624Q37164396-78315B75-6A98-4F55-86D0-43A5BC9C75AEQ37210975-BB0F4B97-319E-4ECD-847C-8B48973D5CC6Q38614137-FDB3D0EA-6C44-4B73-81AC-8E918FF477BEQ38722807-132358ED-A770-4D41-8947-F5E4A4EA73E9Q38749818-82BB4D6C-8DB0-4657-98D4-A94D2F2E31C1Q38769437-F4A10690-C21C-4586-841C-BCED3F11B737Q40249550-2DB6A542-AE2B-415C-87F3-D69A1EC91E9CQ40979051-47F23B3B-D316-425C-8D4D-E22F4DA32D48Q41709320-B81062C6-39F7-4483-AB88-E12BCCAFD5B0Q41733279-CFE9F052-6706-4BE5-9D23-167EBA4E4324Q47748373-825D9DFA-E8AD-423A-ABB1-3ED73F87D44AQ47771443-69D736AD-6B80-409A-BB0C-3F3874398422
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Mesenchymal to epithelial transition in sarcomas.
@en
type
label
Mesenchymal to epithelial transition in sarcomas.
@en
prefLabel
Mesenchymal to epithelial transition in sarcomas.
@en
P2093
P1476
Mesenchymal to epithelial transition in sarcomas.
@en
P2093
Guowen Wang
Jilong Yang
Kelly K Hunt
Kexin Chen
Raphael E Pollock
Xiaoling Du
Xiongzeng Zhu
P304
P356
10.1016/J.EJCA.2013.11.006
P577
2013-11-28T00:00:00Z